AI in drug discovery: the hype vs. the reality
Every week, a new AI drug discovery startup announces a breakthrough. But are they real? The small molecule drug discovery market research study shows that computational drug design is the fastest‑growing technology, with a CAGR above 12%. AI can screen billions of molecules in silico, predict toxicity, and optimise binding affinity. But AI‑generated molecules still need to be...
0 Comments 0 Shares 63 Views 0 Reviews